Ischemic optic neuropathy and giant cell arteritis

Current Opinion in Ophthalmology

Volumn 9, Issue 6, 1998, Pages 10-17

  McFadzean, R M ^a  

^a SOUTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; CALCIUM CHANNEL BLOCKING AGENT; IMMUNOSUPPRESSIVE AGENT;

BLOOD FLOW; GIANT CELL ARTERITIS; ISCHEMIC OPTIC NEUROPATHY; OPTIC NERVE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; VISUAL IMPAIRMENT;

EID: 0031775460     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/00055735-199812000-00003     Document Type: Review

References (82)

1. Hayreh SS: Anterior ischemic optic neuropathy. Clin Neurosci 1997, 4:251-263.
2. Espinel CH: A medical evaluation of Rembrandt. His self-portrait: ageing, disease, and the language of the skin. Lancet 1997, 350:1835-1837.
3. Ghanchi FD, Dutton GN: Current concepts in giant cell (temporal) arteritis. Surv Ophthalmol 1997, 42:99-123.
4. Hunder GG: Giant cell arteritis in polymyalgia rheumatica [editorial]. Am J Med 1997, 102:514-516.
5. Gran JT, Myklebust G: The incidence of polymyalgia rheumatica and temporal arteritis in the county of Aust Agder, south Norway: a prospective study 1987-94. J Rheumatol 1997, 24:1739-1743.
6. Combe B, Sany J, Le Quellac A, Clot J, Eliaou JF: Distribution of HLA-DRB1 alleles of patients with polymylagia rheumatica and giant cell arteritis in a Mediterranean population. J Rheumatol 1998, 25:94-98.
7. Gros F, Maillefert JF, Behin A, Guignier F, Piroth C, Creuzot-Garcher C, Tavernier C: Giant cell arteritis with ocular complications discovered simulteneously in two sisters. Clin Rheumatol 1998, 17:58-61.
8. Cid MC, Font C, Coll-Vinent B, Grau JM: Large vessel vasculitides. Curr Opin Rheumatol 1998, 10:18-28.
9. Nordborg E, Nordborg C: The inflammatory reaction in giant cell arteritis: an immunohistochemical investigation. Clin Exp Rheumatol 1998, 16:165-168.
10. Field M, Cook A, Gallagher G: Immuno-localisation of tumour necrosis factor and its receptors in temporal arteritis. Rheumatol Int 1997, 17:113-118.
11. Genereau T, Peyri N, Berard M, Cherin P, Cabane J, Lehoang P, Guillevin L, Herson S. Boffa M: Human neutrophil elastase in temporal (giant cell) arteritis: plasma and immunohistochemical studies. J Rheumatol 1998, 25:710-713.
12. Kaiser M, Weyand CM, Bjornsson J, Goronzy JJ: Platelet-derived growth factor, intimai hyperplasia, and ischemic complications in giant cell arteritis. Arthritis Rheum 1998, 41:623-633.
13. Navarro M, Cervera R, Font J, Reverter JC, Monteagudo J, Escolar G, Lopez-Soto A, Ordinas A, Ingelmo M: Anti-endothelial cell antibodies in systemic autoimmune diseases: prevalence and clinical significance. Lupus 1997, 6:521-526.
14. Duhaut P, Berruyer M, Pinede L, Demolombe-Rague S, Loire R, Seydoux D, Dechavanne M, Ninet J, Pasquier J: Anticardiolipin antibodies and giant cell arteritis: a prospective, multicenter case-control study. Arthritis Rheum 1998, 41:701-709.
15. Tomita T, Imakawa K: Matrix metalloproteinases and tissue inhibitors of metalloproteinases in giant celt arteritis: an immunocytochemical study. Pathology 1998, 30:40-50.
16. Brack A, Rittner HL, Younge BR, Kaltschmidt C, Weyand CM, Goronzy JJ: Glucocorticoid-mediated repression of cytokine gene transcription in human arteritis-SCID chimeras. J Clin Invest 1997, 99:2842-2850.
17. Brack A, Geisler A, Martinez-Taboada VM, Younge BR, Goronzy JJ, Weyand CM: Giant cell vasculitis is a T cell-dependent disease. Molecular Med 1997, 3:530-543.
18. Hunder GG: Giant cell arteritis. Lupus 1998, 7:266-269.
19. Casado E, Holgado S, Teixido J, Olive A: Giant cell (temporal) arteritis and secondary amyloid: a matter of disease duration? J Rheumatol 1998, 25:822.
20. Glutz-von-Blotzheim S, Borruat FX: Neuro-ophthalmic complications of biopsy-proven giant cell arteritis. Eur J Ophthalmol 1997, 7:375-382.
21. Cid MC, Font C, Oristrell J, de-la-Sierra A, Coll-Vincent B, Lopez-Soto A, Vilaseca J, Urbano-Marquez A, Grau JM: Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis. Arthritis Rheum 1998, 41:26-32.
22. Bahlas S, Ramos-Remus C, Davis P: Clinical outcome of 149 patients with polymylagia rheumatica and giant cell arteritis. J Rheumatol 1998, 25:99-104.
23. Hayreh SS, Podhajsky PA, Zimmerman B: Ocular manifestations of giant cell arteritis. Am J Ophthalmol 1998, 125:509-520.
24. Hayreh SS, Podhajsky PA, Zimmerman B: Occult giant cell arteritis: ocular manifestations. Am J Ophthalmol 1998, 125:521-526.
25. Docken WP: Visual loss and giant cell arteritis [letter]. Br J Rheumatol 1997, 36:823.
26. Bondeson J, Asman P: Giant cell arteritis presenting with oculomotor nerve palsy. Scand J Rheumatol 1997, 26:327-328.
27. Currey J: Scalp necrosis in giant cell arteritis and review of the literature. Br J Rheumatol 1997, 36:814-816.
28. Kranemann CF, Buys YM: Acute angle-closure glaucoma in giant cell arteritis. Can J Ophthalmol 1997, 32:389-391.
29. Kawasaki A, Purvin VA, Tang R: Bilateral anterior ischemic optic neuropathy following influenza vaccination. J Neuroophthalmol 1998, 18:56-59.
30. Finelli PF: Alternating amaurosis fugax and temporal arteritis. Am J Ophthalmol 1997, 123:850-851.
31. Schmidt MH, Fox AJ, Nicolle DA: Bilateral anterior ischemic optic neuropathy as a presentation of Takayasu's disease. J Neuroophthalmol 1997, 17:156-161.
32. Hutnik CM, Nicolle DA, Munoz DG: Orbital aspergillosis: a fatal masquerader. J Neuroophthalmol 1997, 17:257-261.
33. Genereau T, Martin A, Lortholary O, Noel V, Guillevin L: Temporal arteritis symptoms in a patient with hepatitis C virus associated type II cryoglobulinemia and small vessel vasculitis. J Rheumatol 1998, 25:183-185.
34. Diego M, Margo CE: Postural vision loss in giant cell arteritis. J Neuroophthalmol 1998, 18:124-126.
35. Gonzalez-Gay MA, Garcia-Porrua C: Carotid tenderness: an ominous sign of giant cell arteritis? Scand J Rheumatol 1998, 27:154-156.
36. van Laar JM, Tijssen MAJ, Aarts NJM, de Meijer PHEM: Stroke: atherosclerosis or arteritis? J Am Geriat Soc 1998, 46:794-796.
37. Kwok AK, Lam DSC, Liew CT: Bilateral arteritic central retinal artery occlusion in a Chinese patient. Austral N Z J Ophthalmol 1998, 26:175-176.
38. Galetta SL, Balcer LJ, Lieberman AP, Syed NA, Lee JM, Oberholtzer JC: Refractory giant cell arteritis with spinal cord infarction. Neurology 1997, 49:1720-1723.
39. Sudlow C: Diagnosing and managing polymyalgia rheumatica and temporal arteritis: sensitivity of temporal artery biopsy vanes with biopsy length and sectioning strategy [letter]. BMJ 1997, 315:549.
40. Jobanputra P, Richmond R, McRorie E: The value of temporal artery biopsy in suspected cranial arteritis [letter]. Br J Rheumatol 1997, 36:709.
41. Gonzalez-Gay MA, Garcia-Porrua C, Brannas F: Carotid occlusion mimicking giant cell arteritis. J Rheumatol 1998, 25:1247-1248.
42. Schmidt WA, Kraft HE, Vorpahl K, Volker L, Gromnica-Ihle EJ: Color duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med 1997, 337:1336-1342.
43. Myers KA, Farquhar DR: Ultrasonography in temporal arteritis [letter]. N Engl J Med 1998, 338:760.
44. Puechal X, Menkes CJ: Ultrasonography in temporal arteritis [letter]. N Engl J Med 1998, 338:760-761.
45. Lauwerys BR, Puttemans T, Houssiau FA, Devogelaer JP: Color Doppler sonography of the temporal arteries in giant cell arteritis and polymylagia rheumatica. J Rheumatol 1997, 24:1570-1574.
46. Brigden M: The erythrocyte sedimentation rate: still a helpful test when used judiciously. Postgrad Med 1998, 103:257-262.
47. Krishna R, Kosmorsky GS: Implications of thrombocytosis in giant cell arteritis. Am J Ophthalmol 1997, 124:103.
48. Elling P, Olsson AT, Elling H: A reduced CD8+ lymphocyte subset distinguishes patients with polymyalgia rheumatica and temporal arteritis from patients with other diseases. Clin Exp Rheumatol 1998, 16:155-160.
49. Manna R, Latteri M, Cristiano G, Todaro L, Scuderi F, Gasbarrini G: Anticardiolipin antibodies in giant cell arteritis and polymyalgia rheumatica: a study of 40 cases. Br J Rheumatol 1998, 37:208-210.
50. Freeman AG: Diagnosing and managing polymyalgia rheumatica and temporal arteritis: urgency in giving steroids in giant cell arteritis is still not widely appreciated [letter]. BMJ 1997, 315:549-550.
51. Cornblath WT, Eggenberger ER: Progressive visual loss from giant cell arteritis despite high-dose intravenous methylprednisolone. Ophthalmology 1997, 104:854-858.
52. Lee AG: Giant cell arteritis and intravenous methylprednisolone [letter]. Ophthalmology 1998, 105:203.
53. Nesher G, Rubinow A, Sonnenblick M: Efficacy and adverse effects of different corticosteroid dose regimens in temporal arteritis: a retrospective study. Clin Exp Rheumatol 1997, 15:303-306.
54. Finlay R: Diagnosing and managing polymyalgia rheumatica and temporal arteritis: oral prednisolone 40 mgs daily is not adequate for temporal arteritis once vision is affected [letter]. BMJ 1997, 315:549.
55. Gabriel SE, Sunka J, Salvarani C, O'Fallon WM, Hunder GG: Adverse outcomes of anti-inflammatory therapy among patients with polymyalgia rheumatica. Arthritis Rheum 1997, 40:1873-1878.
56. Hodgkins P, Hull R: Diagnosing and managing polymylagia rheumatica and temporal arteritis: patients starting steroids should be given advice on risk of osteoporosis [letter]. BMJ 1997, 315:550.
57. Nordborg E, Schaufelberger C, Andersson R, Bosaeus I, Bengtsson BA: The ineffectiveness of cyclical oral clodronate on bone mineral density in glucocorticoid-treated patients with giant-cell arteritis. J Intern Med 1997, 242:367-371.
58. Nordborg E, Schaufelberger C, Bosaeus I: The effect of glucocorticoids on fat and lean tissue masses in giant cell arteritis. Scand J Rheumatol 1998, 27:106-111.
59. Langford CA, Sneller MC, Hoffman GS: Methotrexate use in systemic vasculitis. Rheum Dis Clin North Am 1997, 23:841-853.
60. Schaufelberger C: No additive effect of cyclosporin A compared with glucocorticoid treatment alone in giant cell arteritis: results of an open, controlled, randomized study. Br J Rheumatol 1998, 37:464-465.
61. Hunder GG, Weyand CM: Sonography in giant cell arteritis [editorial]. N Engl J Med 1997, 337:1385-1386.
62. Portarazu SV: Ischemic optic neuropathy: models for a mechanism of disease. Clin Neurosci 1997, 4:264-269.
63. Girkin CA, Comey CH, Lunsford LD, Goodman ML, Kline LB: Radiation optic neuropathy after stereotactic radiosurgery. Ophthalmology 1997, 104:1634-1643.
64. Lana-Peixoto MA, Barbosa A: Anterior ischemic optic neuropathy in a child with AS haemoglobinopathy and migraine. Br J Ophthalmol 1998, 82:199-200.
65. Moster ML: Visual loss after coronary artery bypass surgery. Surv Ophthalmol 1998, 42:453-457.
66. Shaked G, Gavriel A, Roy-Shapira A: Anterior ischemic optic neuropathy after hemorrhagic shock. J Trauma 1998, 44:923-925.
67. Biousse V, Schaison M, Touboul PJ, D'Anglejan-Chattillon J, Bousser MG: Ischemic optic neuropathy associated with internal carotid artery dissection. Arch Neurol 1998, 55:715-719.
68. Schönhofer PS, Werner B, Tröger U: Ocular damage assciated with proton pump inhibitors. BMJ 1997, 314:1805.
69. Riordan-Eva P, Sanders MD: Omeprazole and ocular damage: facts of cases are unclear [letter]. BMJ 1998, 316:67.
70. Lessell S: Omeprazole and ocular damage: concerns on safety of drug are unwarranted [letter]. BMJ 1998, 316:67.
71. Sachs G: Omeprazole and ocular damage: lack of causality holds true [letter]. BMJ 1998, 316:67-68.
72. Dilger JA, Tetzlaff JE, Bell GR, Kosmorsky GS, Agnor RC, O'Hara JF Jr: Ischemic optic neuropathy after spinal fusion. Can J Anaesthesia 1998, 45:63-66.
73. Worrall BB, Moazami G, Odel JG, Behrens MM: Anterior ischemic optic neuropathy and activated protein C resistance: a case report and review of the literature. J Neuroophthalmol 1997, 17:162-165.
74. Hayreh SS, Podhajsky PA, Zimmerman B: Non-arteritic anterior ischemic optic neuropathy: time of onset of visual loss. Am J Ophthalmol 1997, 124:641-647.
75. Landau K, Winterkorn JMS, Napolitano B: Non-arteritic anterior ischemic optic neuropathy: role of nocturnal arterial hypotension-in reply [letter]. Arch Ophthalmol 1997, 115:943-945.
76. Wilhelm H, Meilinger S, Apfelstedt E: Relation between relative afferent pupillary defect and suprathreshold automated perimetry. Klin Monatsbl Augenheilkd 1997, 210:365-369.
77. Gerling J, Meyer JH, Kommerell G: Visual field defects in optic neuritis and anterior ischemic optic neuropathy: distinctive features. Graefes Arch Clin Exp Ophthalmol 1998, 236:188-192.
78. Hayreh SS: Evaluation of optic nerve head circulation: review of the methods used. J Glaucoma 1997, 6:319-330.
79. Titze P, Hero M, Petrig BL, Cranstoun SD, Riva CE: Autoregulation of human optic nerve head blood flow. Klin Monatsbl Augenheilkd 1997, 210:308-309.
80. Langhans M, Michelson G, Groh MJM: Effect of breathing 100% oxygen on retinal and optic nerve head capillary blood flow in smokers and nonsmokers. Br J Ophthalmol 1997, 81:365-369.
81. 2 in the pig optic nerve head. Klin Monatsbl Augenheilkd 1997, 210:313-315.
82. Kupersmith MJ, Frohman L, Sanderson M, Jacobs J, Hirschfeld J, Ku C, Warren FA: Aspirin reduces the incidence of second eye NAION: a retrospective study. J Neuroophthalmol 1997, 17:250-253.